Healthcare Services Group Inc (HCSG) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Healthcare Services Group Inc   (NASDAQ: HCSG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Healthcare Services Group Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Healthcare Services Group Inc in the second quarter 2026?
Healthcare Services Group Inc achieved a return on average equity (ROE) of 24.12 % in its second quarter 2026, this is above HCSG's average return on equity of 15.47%.
Healthcare Services Group Inc shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $510 million

While the company's net income was fading, Healthcare Services Group Inc was able to improve its ROE compared to the first quarter 2026.

Within the Healthcare Facilities industry 6 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1041 to 1047.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change 8.76 % -0.08 % 2.06 % 1.48 % -
Y / Y Net Income Change - 51.27 % 162.11 % 206.15 % -
Net Income (TTM) in Millions 123 68 59 40 11
Return On Equity (TTM) 24.12 % 13.6 % 11.83 % 8 % 2.18 %
HCSG's Total Ranking # 1047 # 1041 # 1055 # 680 # 222
Equity (TTM) in Millions 519 514 510 496 477
Seq. Equity Change 0.99 % 0.7 % 2.86 % 3.98 % -7.23 %
Seq. Net Income Change -12.91 % -16.59 % -27.26 % - -

Back to HCSG Management Effectiveness >> HCSG's 5 Years Annual ROE >> Compare HCSG ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 7
Sector # 70
Overall # 1047

Return On Equity Statistics
High Average Low
24.17 %
15.47 %
2.18 %
(Sep 30 2017)   (Jun 30 2025)





HCSG Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 510 500 457 426 453
Y / Y Equity Change 2.06 % 9.49 % 7.14 % -5.86 % -5.78 %
Net Income in Millions 59 39 38 35 46
Y / Y Net Income Change 49.63 % 2.83 % 10.85 % -24.49 % -53.52 %
Return On Equity 11.58 % 7.9 % 8.41 % 8.13 % 10.13 %

Back to HCSG Management Effectiveness >> HCSG's 5 Years Annual ROE >> Compare HCSG ROE to its Competitors




Annual Roe Comment
In 2025 ROE improved to 11.58 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HCSG's' Return on Equity at Yahoo Finance
HCSG's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HCSG's Competitors
Subscribers only: Roe for Healthcare Services Group Inc 's Suppliers
Subscribers only: Return On Equity for HCSG's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Earth Science Tech Inc   66.17 %
Aurinia Pharmaceuticals Inc   59.00 %
Vaxart Inc   53.04 %
Qhslab Inc   51.21 %
Tenet Healthcare Corp  50.64 %
Nrc Health  48.29 %
Concentra Group Holdings Parent Inc   48.13 %
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %

Date modified: 2026-09-20T03:42:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.